R63L (p.Arg63Leu) variant of TECTA (Alpha-tectorin)

R63L (p.Arg63Leu) in TECTA (Alpha-tectorin) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.60 / 1. The record also includes population frequency data and structural context.

R63L (p.Arg63Leu) variant details